Showing posts with label senate veterans. Show all posts
Showing posts with label senate veterans. Show all posts

16 July 2014

Acting VA Secretary Seeks $18 Billion Extra to Solve Problems

Veterans Affairs Department officials want nearly $18 billion more in funding over the next three years to hire more clinicians, lease more space and cut down on wait times for medical appointments.
The money is also partly designed to serve as a down payment on rebuilding VA's reputation, proving to the public that with enough resources, the department can once again be a reliable asset for veterans seeking care.
In his first testimony on Capitol Hill, acting VA Secretary Sloan Gibson acknowledged to the Senate Veterans' Affairs Committee that VA today "has serious problems" that will take years to correct.
"We understand the problems we face. We own them. We are taking decisive action to begin to resolve them," Gibson said. "We can turn these challenges into the greatest opportunity for improvement in the history of the department."
Those challenges include nearly nonstop scandals over the past four months, including recent revelations about whistleblower retaliation and data manipulation in dozens of facilities.
But the overarching issue that forced the resignation of Gibson's predecessor — retired Army Gen. Eric Shinseki, who stepped down in May — was system wait time problems, covered up by administrators trying to protect performance bonuses.
As of July 3, more than 636,000 veterans — about 10 percent of VA's total appointment caseload — faced a wait of a month or more for medical appointments,
To fix that, Gibson wants to hire 10,000 clinicians in coming years and find more space for medical appointments through leases, VA facility improvements and new construction — moves that he said would provide not only a short-term fix but also a longer-term solution to the underlying resource issues.
"I know it sounds like huge numbers," he told lawmakers. "But [VA] historically has not managed to veterans' requirements, we've managed to budget numbers."
Congress is already considering an emergency VA reform bill that would boost funding by about $30 billion over the next three years, according to Congressional Budget Office estimates. But that measure would allot only $500 million to new hiring initiatives; the rest would be used to increase access to private care options for veterans having trouble accessing VA care.
The department already has seen dramatic jumps in funding over the last decade, adding about $100 billion to its base budget since fiscal 2004 and about $70 billion since fiscal 2008.
The additional funding request drew concerns from several senators, who questioned whether better management and use of existing resources would provide more results for veterans.
But Gibson insisted that addressing the fundamental problems behind the wait times will require more resources, and failing to back those plans "will mean that the wait times will get longer."
He also outlined a number of recent audits and policy updates to address the other scandals, and repeated his promise that VA whistleblowers will be protected — and those who retaliate against them will face punishment.

10 January 2014

VA Disability Compensation: Dioxin & Ischemic Heart Disease Statement by Dr Linda Birnbaum

Statement by
Linda S. Birnbaum, Ph.D., DABT, ATS
Director
National Institute of Environmental Health Sciences
National Institutes of Health
Director, National Toxicology Program
Department of Health and Human Services
on
VA Disability Compensation: Presumptive Disability Decision-Making 
before
Committee on Veterans’ Affairs
United States Senate

Thursday September 23, 2010 (note: updated June 2013)
Mr. Chairman and distinguished members of the Committee—I am pleased to appear before you today to present testimony on the relationship between dioxin exposure and the risk of ischemic heart disease. My name is Linda Birnbaum; I am the Director of the National Institute of Environmental Health Sciences (NIEHS), of the National Institutes of Health, an agency of the Department of Health and Human Services, and Director of the National Toxicology Program (NTP), an interagency program, housed at NIEHS, whose mission is to evaluate agents of public health concern by developing and applying tools of modern toxicology and molecular biology. The program maintains an objective, science-based approach in dealing with critical issues in toxicology and is committed to using the best science available to prioritize, design, conduct, and interpret its studies.
Understanding the role that environmental and occupational exposures play in the development of chronic diseases can be challenging, particularly for diseases that have significant risk factors in addition to the chemical exposure. Thus, the task of estimating the quantitative role of Agent Orange and dioxin exposure in the development of ischemic heart disease in Vietnam Veterans is clouded by the contributions of other risk factors such as age, smoking, family history, body mass index, serum lipid concentrations, and other factors. In 2008, my colleagues and I published a systematic review that evaluated the evidence of an association between dioxin exposure and cardiovascular disease mortality in humans.1 We found that the studies in the highest-quality group found consistent and significant dose-related increases in ischemic heart disease mortality and concluded that there is an association between dioxin exposure and mortality from ischemic heart disease and cardiovascular disease.